Obesity is a chronic disease whose prevalence - especially in the Western world - is increasing to epidemic proportions. The accepted therapeutic paradigm for the treatment of obesity is a behavioral change in lifestyles.
New treatments are expected to be added in the coming years. The potential inherent in drug treatments for the disease of obesity, as well as the desire to expand the target audience, led the pharmaceutical giants to try to develop drugs also in pills and not just by subcutaneous injection. The American Food and Drug Administration (FAD) estimated that in light of the great demand in the world, a shortage is expected.